067080 — Dae Hwa Pharm Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩178bn
- KR₩291bn
- KR₩141bn
- 27
- 30
- 28
- 14
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 8,901 | 6,390 | 12,302 | 4,722 | 5,838 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 19,907 | 18,014 | 18,236 | 19,451 | 24,536 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 49,777 | 50,926 | 56,139 | 51,213 | 65,220 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 68,913 | 68,778 | 68,245 | 89,857 | 94,351 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 166,145 | 175,047 | 177,376 | 199,056 | 219,163 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 70,680 | 77,608 | 75,335 | 83,260 | 127,948 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 86,798 | 93,068 | 97,702 | 121,064 | 145,931 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 79,347 | 81,979 | 79,674 | 77,993 | 73,232 |
Total Liabilities & Shareholders' Equity | 166,145 | 175,047 | 177,376 | 199,056 | 219,163 |
Total Common Shares Outstanding |